Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Critical Reviews in Immunology|January 1, 1988
Future prospects for vaccine adjuvantsH S Warren, L A ChedidReviews of Infectious Diseases|September 1, 1987
Strategies for the treatment of endotoxemia: significance of the acute-phase responseH S Warren, L A ChedidInfection and Immunity|January 1, 1988
Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factorH S Warren, G R Riveau, F A de Deckker, et al.Viral Immunology|January 1, 1993
Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptideM C Gauduin, F R Vogel, J P Simon, et al.International Journal of Immunopharmacology|February 1, 1995
The role of adjuvants in retroviral vaccinesF R VogelClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Improving vaccine performance with adjuvantsF R VogelAnnals of the New York Academy of Sciences|May 31, 1995
Immunologic adjuvants for modern vaccine formulationsF R VogelInfection and Immunity|June 1, 1986
Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell cultureF Dubor, A M Dosne, L A ChedidCellular Immunology|July 1, 1987
Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptidesG M Bahr, L A Chedid, K BehbehaniPageof 11